IL192662A - Quinolones iii are preserved, a method of preparing them and medicaments containing them - Google Patents

Quinolones iii are preserved, a method of preparing them and medicaments containing them

Info

Publication number
IL192662A
IL192662A IL192662A IL19266208A IL192662A IL 192662 A IL192662 A IL 192662A IL 192662 A IL192662 A IL 192662A IL 19266208 A IL19266208 A IL 19266208A IL 192662 A IL192662 A IL 192662A
Authority
IL
Israel
Prior art keywords
medicaments
iii
preparation
substituted quinolones
quinolones
Prior art date
Application number
IL192662A
Other languages
English (en)
Hebrew (he)
Other versions
IL192662A0 (en
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of IL192662A0 publication Critical patent/IL192662A0/en
Publication of IL192662A publication Critical patent/IL192662A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL192662A 2006-02-09 2008-07-07 Quinolones iii are preserved, a method of preparing them and medicaments containing them IL192662A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006005861A DE102006005861A1 (de) 2006-02-09 2006-02-09 Substituierte Chinolone III
PCT/EP2007/000923 WO2007090579A2 (de) 2006-02-09 2007-02-02 Substituierte chinolone iii

Publications (2)

Publication Number Publication Date
IL192662A0 IL192662A0 (en) 2009-08-03
IL192662A true IL192662A (en) 2013-04-30

Family

ID=38283107

Family Applications (1)

Application Number Title Priority Date Filing Date
IL192662A IL192662A (en) 2006-02-09 2008-07-07 Quinolones iii are preserved, a method of preparing them and medicaments containing them

Country Status (27)

Country Link
US (1) US7977349B2 (https=)
EP (1) EP1994020B1 (https=)
JP (1) JP5198291B2 (https=)
KR (1) KR101400568B1 (https=)
CN (1) CN101379055B (https=)
AR (1) AR059417A1 (https=)
AT (1) ATE513826T1 (https=)
AU (1) AU2007214006B2 (https=)
BR (1) BRPI0706988A2 (https=)
CA (1) CA2637204C (https=)
CY (1) CY1111805T1 (https=)
DE (1) DE102006005861A1 (https=)
DK (1) DK1994020T3 (https=)
DO (1) DOP2007000027A (https=)
ES (1) ES2366970T3 (https=)
IL (1) IL192662A (https=)
MY (1) MY151590A (https=)
PE (1) PE20080113A1 (https=)
PL (1) PL1994020T3 (https=)
PT (1) PT1994020E (https=)
RU (1) RU2433125C2 (https=)
SI (1) SI1994020T1 (https=)
TW (1) TWI382980B (https=)
UA (1) UA94934C2 (https=)
UY (1) UY30135A1 (https=)
WO (1) WO2007090579A2 (https=)
ZA (1) ZA200806355B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059339A1 (es) * 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
TW200811153A (en) 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
JP7120549B2 (ja) * 2016-12-15 2022-08-17 小野薬品工業株式会社 Trek(twik関連kチャネル)チャネルのアクチベータ
US11572357B2 (en) 2018-05-09 2023-02-07 Bayer Animal Health Gmbh Quinoline derivatives

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932487A (en) 1960-07-25 1963-07-31 D G Searle & Co Piperidine derivatives
DE3420743A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0241206A3 (en) 1986-03-31 1989-05-10 Sankyo Company Limited Quinoline-3-carboxylic acid derivatives, their preparation and use
DE3702393A1 (de) 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
AU618823B2 (en) 1988-07-20 1992-01-09 Sankyo Company Limited 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
US4959363A (en) 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
DE4303657A1 (de) 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR0169500B1 (ko) * 1993-08-13 1999-01-15 이우용 새로운 퀴놀론 카르복실산 유도체 및 그의 제조방법
FR2713116B1 (fr) 1993-11-30 1996-01-12 Techmetal Promotion Dispositif d'alimentation pour le dépôt par simple gravité d'un matériau granuleux sur la surface d'un métal liquide coulé en continu.
KR960004339A (ko) 1994-07-02 1996-02-23 임성기 신규한 퀴놀린계 화합물 및 그 의 제조방법
PT841929E (pt) 1995-08-02 2003-09-30 Darwin Discovery Ltd Quinolonas e sua utilizacao terapeutica
WO1997004775A1 (en) 1995-08-02 1997-02-13 Chiroscience Limited Quinolones and their therapeutic use
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
DE19937024A1 (de) 1999-08-05 2001-02-08 Bayer Ag Verwendung von Acylsulfonamido substituierten Polymethin-Farbstoffen als Fluoreszenz-Farbstoffe und/oder Marker
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
WO2002009758A2 (en) 2000-08-01 2002-02-07 Wockhardt Limited Inhibitors of cellular efflux pumps of microbes
GB0023918D0 (en) 2000-09-29 2000-11-15 King S College London Antiparasitic compounds
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2005511743A (ja) 2001-12-13 2005-04-28 ウォックハート・リミテッド 新世代の三重標的化したキラルな広域スペクトラム抗菌性の7位置換ピペリジノ−キノロンカルボン酸誘導体、その調製方法、組成物、および医薬としての使用
BRPI0409105A (pt) 2003-04-07 2006-04-25 Cylene Pharmaceuticals Inc análogos de quinobenzoxazina substituìdos
WO2005049602A1 (en) * 2003-11-18 2005-06-02 Warner-Lambert Company Llc Quinolone antibacterial agents
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
DE102005030524A1 (de) 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituierte Chinolone II

Also Published As

Publication number Publication date
KR20080100248A (ko) 2008-11-14
RU2008136079A (ru) 2010-03-20
UY30135A1 (es) 2007-09-28
DOP2007000027A (es) 2007-10-31
US7977349B2 (en) 2011-07-12
HK1125372A1 (zh) 2009-08-07
CN101379055B (zh) 2012-12-05
US20090181996A1 (en) 2009-07-16
IL192662A0 (en) 2009-08-03
MY151590A (en) 2014-06-13
WO2007090579A2 (de) 2007-08-16
AR059417A1 (es) 2008-04-09
PL1994020T3 (pl) 2011-10-31
AU2007214006B2 (en) 2011-11-03
JP5198291B2 (ja) 2013-05-15
RU2433125C2 (ru) 2011-11-10
SI1994020T1 (sl) 2011-10-28
EP1994020B1 (de) 2011-06-22
BRPI0706988A2 (pt) 2011-04-19
WO2007090579A3 (de) 2007-11-15
CY1111805T1 (el) 2015-10-07
AU2007214006A1 (en) 2007-08-16
CA2637204C (en) 2013-04-16
PT1994020E (pt) 2011-09-02
CN101379055A (zh) 2009-03-04
ES2366970T3 (es) 2011-10-27
ZA200806355B (en) 2010-02-24
CA2637204A1 (en) 2007-08-16
DE102006005861A1 (de) 2007-08-23
JP2009525999A (ja) 2009-07-16
PE20080113A1 (es) 2008-04-18
KR101400568B1 (ko) 2014-05-26
EP1994020A2 (de) 2008-11-26
TWI382980B (zh) 2013-01-21
ATE513826T1 (de) 2011-07-15
TW200808757A (en) 2008-02-16
DK1994020T3 (da) 2011-09-19
UA94934C2 (uk) 2011-06-25

Similar Documents

Publication Publication Date Title
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
GB0625995D0 (en) Method for preparing a composition
IL195224A0 (en) Delivery method
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
PL2185009T3 (pl) Napój i sposób jego wytwarzania
PL2106225T3 (pl) Pościel aromaterapeutyczna i sposób jej wytwarzania
ZA201001009B (en) Micro-particles, blood-substitute and method for forming same
GB2478251B (en) System and method for providing a table game
GB0721332D0 (en) Medicaments
PL1942967T3 (pl) Sposób dozowania leków
EP1848679A4 (en) PROCESS FOR THE PREPARATION OF TRIMETHYLOLPROPANE
IL192662A (en) Quinolones iii are preserved, a method of preparing them and medicaments containing them
GB2456999B (en) Method for preparing 2-deoxy-L-ribose
EP2016706A4 (en) METHOD AND ARRANGEMENT FOR VIRTUAL MEETING
GB0621562D0 (en) Network administration
PL1999112T3 (pl) Podstawione 2-amino-4-fenylo-dihydrochinoliny, sposób ich wytwarzania, ich zastosowanie jako leku i lek je zawierający
GB0721991D0 (en) Preparation method
EP2114883A4 (en) PROCESS FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE
GB0613031D0 (en) Medicaments
EP2210400A4 (en) METHOD OF SUPPORTING PACKET EVENT
PL1820632T5 (pl) Sposób i układ do wytwarzania jednostki opakowaniowej
IL197022A0 (en) Novel preparation method
PL1917655T3 (pl) System z korpusem świecącym oraz korpus świecący do systemu z korpusem świecącym
ZA200800479B (en) Gaming system, gaming machine and gaming method

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees